AstraZeneca

Tecentriq
Favicon Fierce Pharma

Roche touts Tecentriq biomarker win in bladder cancer

Roche's biomarker-driven adjuvant approach differs from the perioperative route taken by AstraZeneca and a Pfizer-Astellas-Merck trio.
Angus Liu Aug 18, 2025 4:17pm
mRNA vaccine

HHS cancels mRNA vaccine development funded by BARDA

Aug 5, 2025 7:20pm
Clear out clearnance rubbish scrap heap

AstraZeneca drops lead TCR therapy from $200M Neogene buy

Jul 29, 2025 4:13am
hiring new hire appointment executive

BMS names AZ's Cristian Massacesi as new chief medical officer

Jul 25, 2025 9:26am
Graphic image of an arrow nailing the bullseye of a target

AstraZeneca's blockbuster contender hits phase 3 gMG goals

Jul 24, 2025 6:20am
Pascal Soriot
Favicon Fierce Pharma

AZ reveals plan for huge site in Virginia, part of $50B US outlay

Jul 22, 2025 7:45am